Yujia Cai
-
- CRISPR and Genetic Engineering 13
- RNA Interference and Gene Delivery 6
- Advanced biosensing and bioanalysis techniques 5
- Retinal Development and Disorders 3
- Receptor Mechanisms and Signaling 3
- Genetics top 10%
- Virus-based gene therapy research 11
- Ophthalmology top 10%
-
- Advanced Nanomaterials in Catalysis 4
-
- Herpesvirus Infections and Treatments 4
- Co-authors
- Jacob Giehm MikkelsenRasmus O. BakDawei WangSikai LingJiaxu HongSøren R. PaludanDi YinYao Dai
- Partner nations
- ChinaDenmarkUnited States
In The Last Decade
Yujia Cai
31 papers receiving 858 citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Business and International Management 33
- Molecular Biology 650
- Genetics 257
- Ophthalmology 57
- Aging 10
Countries citing papers authored by Yujia Cai
This map shows the geographic impact of Yujia Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yujia Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yujia Cai more than expected).
Fields of papers citing papers by Yujia Cai
This network shows the impact of papers produced by Yujia Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yujia Cai. The network helps show where Yujia Cai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yujia Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapybreakdown → | 2025 | 18 |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 11 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 15 | |
| 8 | 2023 | 10 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 52 | |
| 11 | 2022 | 35 | |
| 12 | 2022 | 5 | |
| 13 | Targeting herpes simplex virus with CRISPR–Cas9 cures herpetic stromal keratitis in micebreakdown → | 2021 | 122 |
| 14 | 2021 | 135 | |
| 15 | 2020 | 29 | |
| 16 | 2020 | 25 | |
| 17 | 2017 | 60 | |
| 18 | 2016 | 8 | |
| 19 | 2014 | 11 | |
| 20 | 2013 | 29 |
About Yujia Cai
Yujia Cai is a scholar working on Behavioral Neuroscience, Genetics and Molecular Biology, having authored 36 papers that have together received 871 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (13 papers), Virus-based gene therapy research (11 papers), RNA Interference and Gene Delivery (6 papers), Advanced biosensing and bioanalysis techniques (5 papers), Advanced Nanomaterials in Catalysis (4 papers), Herpesvirus Infections and Treatments (4 papers), Retinal Development and Disorders (3 papers) and Receptor Mechanisms and Signaling (3 papers). The work is most often cited by research in Business and International Management (33 citations), Molecular Biology (650 citations) and Genetics (257 citations). Yujia Cai has collaborated with scholars based in China, Denmark and United States. Frequent co-authors include Jacob Giehm Mikkelsen, Rasmus O. Bak, Dawei Wang, Sikai Ling, Jiaxu Hong, Søren R. Paludan, Di Yin, Yao Dai, Xujiao Zhou and Hao Jiang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.